Mediject going after nthe DNA vaccine market;
Monday November 1, 12:56 pm Eastern Time
Company Press Release
SOURCE: Medi-Ject Corporation
Medi-Ject Corporation and BA Tech
Combine Technologies in Test to
Improve DNA Vaccines
Search for Synergistic Effects of Novel Drug Delivery and Adjuvant With Needle-Free Pressure Injection
MINNEAPOLIS, Nov. 1 /PRNewswire/ -- Medi-Ject Corporation (Nasdaq: MEDJ - news) today announced that it has formed a collaborative research alliance with Ben-Abraham Technologies, Inc., (``BA Tech,' Alberta Stock Exchange: BAI; Pink Sheets: BNHT) of Lincolnshire, Ill., to evaluate the efficacy of combining their novel nano-particle drug delivery and adjuvant system with needle-free pressure injection. The research alliance will evaluate the ability of the combined systems to improve immune responses to DNA vaccines. Previous studies have demonstrated the value of
each separate technology with conventional or DNA vaccination models. The new experiments will be conducted as part of a DNA vaccine program at a major U.S. university.
``We were pleased to see a recent publication demonstrating that our needle-free injector enhanced immune responses in models of DNA vaccination,' said Dr. Franklin Pass, Chairman and CEO of Medi-Ject Corporation. ``The BA Tech drug delivery and adjuvant system offers us the opportunity to advance our DNA vaccine program with complementary technology and an experimental immunology research group.'
``Our drug delivery and adjuvant system is aimed at overcoming some limitations of the gold particle adjuvant studies reported in the literature,' commented Stephen Simes, CEO of BA Tech.
``Medi-Ject injectors offer the flexibility of both immunization routes being studied for DNA vaccines, injection within the skin or within the muscle, unlike other similar systems that inject only within the skin. Based on our preclinical work to date, we believe our combined technologies may prove useful in DNA vaccine delivery.'
This gives Medi-Ject a new competitive edge. It is the first mention of DNA vaccine potential. The competition mentioned is Powderject but only indirectly by way of gold particle system...
later,art |
